Kidneys And Genito-Urinary System - Benign Prostatic Hyperplasia Drug Pipeline Report Provides Detail On The Top 20 Companies With Products In The Early And Late Stage Of Development
Posted on: Thursday, 20 September 2007, 12:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68987) has announced the addition of Kidneys and Genito-Urinary System - Benign Prostatic Hyperplasia Drug Pipeline Report to their offering.
"Kidneys and Genito-Urinary System - Benign Prostatic Hyperplasia Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of benign prostatic hyperplasia drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Content Outline:
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Benign Prostatic Hyperplasia Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Benign Prostatic Hyperplasia Projects
--Top 20 companies in early stage Benign Prostatic Hyperplasia Projects
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c68987.
Source: Business Wire
Related Articles
- New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies
- Lightwave Logic Develops a Successful Fabrication Process and Completes Production of its First Prototype Phase Modulators
- An Obesity Drug Pipeline Report: The Development of Therapies for a Complex Disease
- PSTS China to Commence Production Expansion Project
- Toreador Announces Start of Production From Dogu Ayazli Platform, Provides Operational Update and Preliminary Second Phase Development Plan Offshore Turkey
- IBC Expands Coverage of Case Studies and Projects in Preclinical, Phase 1 and Phase 2
- Morse LLC Announces Intent to Develop Proton Therapy Center in South Florida Using Technology From Varian Medical Systems
- CepTor Executes LOI With Ferring for Late Stage Product; Superoxide Dismutase Targeted for Phase 2B Clinical Trials
- AGTC and JDRF Announce Partnership to Develop Gene Therapy for Diabetic Eye Disease
- Indiana Health Information Exchange Selected to Participate in First Phase Development of RHIO Best Practices
 |
 |
User Comments (0)
RSS Feeds